Invst Guru

This episode explores the independent film project We Could Be Heroes through the lens of Regulation Crowdfunding. The discussion focuses on the story’s origin in gaming culture, the creative vision behind the script, and the production approach centered on disciplined scope and execution.Listeners hear how the filmmaking team approaches character-driven storytelling, audience alignment, and modern distribution paths across digital platforms. The episode also addresses the realities of independent film economics, including competition for distribution, audience uncertainty, and long time horizons.This conversation is informational only. No investment terms are discussed. If the project is associated with an active Regulation Crowdfunding campaign, all investments must occur through the official offering page hosted by a registered intermediary. Prospective investors should review the Form C and complete risk disclosures before making any investment decision.

Feeding tube dislodgement affects families and caregivers long after hospital discharge, yet securement methods have changed little over time. In this episode, we examine Ezalife, a medical device company developing the Button Huggie, an FDA registered product designed to stabilize gastrostomy buttons in home care settings.We discuss the clinical problem Ezalife aims to address, the founder’s background in pediatric surgery, internal clinical study findings, early commercial activity, and the challenges of scaling within regulated healthcare markets. The conversation also explores reimbursement uncertainty, hospital adoption dynamics, and the realities of early stage medical device companies raising capital through Regulation Crowdfunding.This episode is for informational purposes only. It does not constitute investment advice or a solicitation to invest. If Ezalife is conducting a Regulation Crowdfunding offering, all investments must be made through its registered funding portal after reviewing the company’s official SEC filings and risk disclosures.

Caring for a child with a feeding tube is not just a medical challenge. It is an everyday emotional and logistical burden for families. Dislodged tubes, emergency room visits, interrupted sleep, and constant anxiety are part of daily life for many parents.In this episode of Invst Guru, host Jeff “fuzzy” Wenzel speaks with the team behind Ezalife, a pediatric medical device company focused on solving one very specific but deeply impactful problem. Keeping feeding tubes secure so kids can move, play, and live more normal lives.Ezalife developed a simple, FDA-exempt securement device that helps reduce accidental tube dislodgement and gives parents peace of mind at home, at school, and on the go. What started as a pediatric surgeon’s idea has grown into a company working to establish a new standard of care for children with G-tubes.In this conversation, we cover:• The real daily challenges families face when caring for children with feeding tubes. • Why small medical problems often lead to big emotional stress? • How a simple product can prevent unnecessary ER visits? • Why Ezalife chose a direct-to-consumer approach before hospital adoption? • How parent-to-parent advocacy drives growth in pediatric healthcare? • The realities of building and manufacturing a medical device. • Fundraising, crowdfunding, and the path to broader hospital and insurance adoption.This episode is for parents, caregivers, healthcare professionals, medtech founders, and investors who want to understand how thoughtful design and patient-first thinking can make a meaningful difference in real lives.

Women’s soccer is growing at an unprecedented pace, yet many talented athletes still fall through the cracks between youth, college, and professional play. The system rewards short-term performance but often fails to support long-term development, wellbeing, and access.In this episode of Invst Guru, host Jeff “fuzzy” Wenzel explores how TLH Reckoning is building a new model for women’s soccer that prioritizes people, community, and sustainable growth.The conversation dives into the real challenges facing women’s sports today, including limited access to capital, broken development pathways, and the lack of infrastructure in non-metro and rural regions. You’ll hear how TLH Reckoning is addressing these gaps by creating a holistic ecosystem that supports athletes on and off the field.This episode covers:⚽ Why the traditional youth-to-college-to-pro pipeline leaves many players behind? ⚽ How community-based teams can unlock access and long-term loyalty? ⚽ The importance of player care, including mental health, workload management, and advocacy. ⚽ Why women’s sports represent a powerful investment opportunity, not a charity case? ⚽ How facilities, academies, and local partnerships drive sustainable growth? ⚽ What success looks like beyond wins, losses, and headlines?This is a must-listen for anyone interested in women’s sports, impact-driven entrepreneurship, community ownership, or the future of athletic development.Whether you are an investor, founder, athlete, parent, or fan, this episode offers a grounded and thoughtful look at how women’s soccer can be built differently and built better.

This episode explores CyberGlobal’s approach to delivering cybersecurity services through a distributed model. You learn how the company pairs a central security operations structure with regional operators who manage customer relationships. We break down the market problem, the service framework, and the operational factors that shape this type of business. The conversation also covers strengths and challenges, including execution demands, training needs, and competition in the security services market. This episode is for listeners who want a clear look at a growing cybersecurity model and the factors that influence performance and scale.This content is informational only. It is not investment advice. If CyberGlobal is engaged in fundraising, all official information appears on its designated Reg CF portal.

Biotech is booming, but access to certified wet labs and affordable space remains one of the biggest barriers for early stage founders. In this episode of Invst Guru, host Jeff “fuzzy” Wenzel sits down with Dr. Anton Dormer, founder of Biolabshare, to explore how he is building a new kind of biotech incubator that blends real estate, innovation, community, and startup support into one ecosystem.Born from Anton’s own entrepreneurial challenges, Biolabshare aims to give biotech innovators a place to work, live, collaborate, and scale. With a ground up lab development underway on family land in Huntsville, Alabama, Biolabshare is designed to serve as an affordable, full service launchpad for life science startups.You’ll hear how Biolabshare focuses on:🔬 Certified wet labs that meet NIH and BARDA standards. 🏢 A real estate model that includes co living for founders. 🧪 Incubator support for up to 20 companies working in biotech, diagnostics, and health AI. 🎓 University partnerships that bring trained interns into the ecosystem. 📈 Startup equity opportunities that generate long term investor returns. 🌱 Affordable access to lab space, equipment, and mentorship. 🏗️ A two phase construction roadmap designed for rapid expansion. 💰 A path to liquidity through company graduations, exits, and a future public listing.Anton also shares the risks, regulatory challenges, and opportunities shaping the biotech industry today, plus how founders can accelerate discovery when they have the right ecosystem behind them.Whether you're a biotech founder, real estate investor, student, or someone fascinated by how life science innovation actually happens, this episode gives you a ground level view into a powerful new model for building the future of health and technology.

In this episode of Invst Guru, host Jeff “fuzzy” Wenzel sits down with Mel Sautter, co-founder of MVP Kids, to explore a powerful mission: helping parents and educators raise confident, emotionally intelligent, and character-driven children.What began as a personal moment with Mel’s young daughter quickly evolved into a 10-year journey of developing books, curriculum, characters, and a soon-to-launch animated series designed to shape children from birth through age 12.You’ll hear how MVP Kids created:✨ A unique 16-character universe that represents diverse personalities and learning styles. ✨ A comprehensive “character Bible” built with child psychologists and educators. ✨ A zero-agenda approach focused on universal virtues, not political or religious narratives. ✨ A structured learning pathway that builds emotional intelligence, social skills, and resilience. ✨ An upcoming animated series created with storytelling legend John Semper. ✨ A global partnership network that unlocks streaming, licensing, merchandising, and distribution opportunities.Mel also explains how MVP Kids protects its intellectual property, works with top animation studios, and builds trust with families in a digital world filled with overstimulation and hidden agendas.For investors, Mel breaks down how children’s education brands generate revenue through international broadcasting, licensing, merchandise, curriculum, and character-driven ecosystems.This episode is perfect for: ✔️ Parents. ✔️ Educators. ✔️ Investors. ✔️ Animators. ✔️ Anyone passionate about raising strong, empathetic, resilient kids.If you want to understand how meaningful children’s content is created and why it matters, this conversation delivers clarity, heart, and real vision for the future.

🎙️ Episode DescriptionIn this episode, we explore Tahiro, a cognitive wellness company working to bridge scientific research with consumer health products. We discuss the market forces shaping the brain health sector, the company’s use of nano-formulation techniques, and the challenges early-stage wellness brands face in standing out in a crowded field. We also review both the bullish and bearish factors observers often consider when evaluating emerging companies in this space.This conversation is designed to offer context, not conclusions. We look at what the company reports publicly, how it frames its research, and where uncertainties remain, including the gap between preclinical data and human outcomes.Disclaimer:This episode is for informational and educational purposes only and is not investment advice or an offer to invest. Invst Guru does not recommend or endorse any securities. If Tahiro is conducting a Regulation Crowdfunding campaign, all investment activity must occur through the registered funding portal that hosts the offering, where official documents, risks, and disclosures are available.